Quantitation of benzo[ a]pyrene-DNA adducts by postlabeling with 14C-acetic anhydride and accelerator mass spectrometry

Quantitation of carcinogen-DNA adducts provides an estimate of the biologically effective dose of a chemical carcinogen reaching the target tissue. In order to improve exposure-assessment and cancer risk estimates, we are developing an ultrasensitive procedure for the detection of carcinogen-DNA add...

Full description

Saved in:
Bibliographic Details
Published inChemico-biological interactions Vol. 126; no. 3; pp. 171 - 183
Main Authors Goldman, Radoslav, Day, Billy W, Carver, Tonya A, Mauthe, Robert J, Turteltaub, Kenneth W, Shields, Peter G
Format Journal Article
LanguageEnglish
Published Ireland Elsevier Ireland Ltd 01.06.2000
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Quantitation of carcinogen-DNA adducts provides an estimate of the biologically effective dose of a chemical carcinogen reaching the target tissue. In order to improve exposure-assessment and cancer risk estimates, we are developing an ultrasensitive procedure for the detection of carcinogen-DNA adducts. The method is based upon postlabeling of carcinogen-DNA adducts by acetylation with 14C-acetic anhydride combined with quantitation of 14C by accelerator mass spectrometry (AMS). For this purpose, adducts of benzo[ a]pyrene-r-7, t-8-dihydrodiol- t-9,10-epoxide (BPDE) with DNA and deoxyguanosine (dG) were synthesized. The most promutagenic adduct of BPDE, 7 R,8 S,9 R-trihydroxy-10S-(N 2-deoxyguanosyl)-7,8,9,10-tetrahydrobenzo[ a]pyrene (BPdG), was HPLC purified and structurally characterized. Postlabeling of the BPdG adduct with acetic anhydride yielded a major product with a greater than 60% yield. The postlabeled adduct was identified by liquid chromatography–mass spectrometry as pentakis(acetyl) BPdG (AcBPdG). Postlabeling of the BPdG adduct with 14C-acetic anhydride yielded a major product coeluting with an AcBPdG standard. Quantitation of the 14C-postlabeled adduct by AMS promises to allow detection of attomolar amounts of adducts. The method is now being optimized and validated for use in human samples.
ISSN:0009-2797
1872-7786
DOI:10.1016/S0009-2797(00)00160-5